Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: Evidentiary base

Journal of the Canadian Urological Association

Volumn 4, Issue 1, 2010, Pages 13-25

  Chin, Joseph L ^a   Srigley, John ^b   Mayhew, Linda A ^c   Bryan Rumble, R ^b   Crossley, Claire ^d   Hunter, Amber ^b   Fleshner, Neil ^c   Bora, Bish ^e   McLeod, Robin ^b   McNair, Sheila ^b   Langer, Bernard ^b   Evans, Andrew ^f  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d CANADIAN INSTITUTE FOR HEALTH INFORMATION   (Canada)

^e SUDBURY REGIONAL HOSPITAL   (Canada)

^f TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76149127375     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.08105     Document Type: Article

References (73)

1. Neutel CI, Gao RN, Blood PA, et al. Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000. Can J Public Health 2006;97:177-82.
2. Neutel CI, Gao RN, Blood PA, et al. The changing age distribution of prostate cancer in Canada. Can J Public Health 2007;98:60-4.
3. Srigley JR. Key issues in handling and reporting radical prostatectomy specimens. Arch Pathol Lab Med 2006;130:303-17.
4. Srigley JR, Amin MB, Epstein JI, et al. Prostate: protocol applies to invasive carcinomas of the prostate gland [monograph online]. Northfield, IL: College of American Pathologists; 2006. http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2006/prostate06_pw.pdf. Accessed December 1, 2009.
5. Gleave ME, Coupland D, Drachenberg D, et al. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 1996;47:708-12.
6. Haukaas S, Roervik J, Halvorsen OJ, et al. When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br J Urol 1997;79:770-6.
7. D'Amico AV, Whittington R, Malkowicz SB, et al. Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J Clin Oncol 2000;18:3240-6.
8. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502-12
9. Chin JL, Srigley J, Mayhew LA, et al. Guideline for Optimization of Surgical and Pathological Quality Performance for Radical Prostatectomy in Prostate Cancer Management: Surgical and Pathological Guidelines. http://www.cancercare.on.ca/toolbox/qualityguidelines/clin-program/surgery-ebs/. Accessed December 2, 2009.
10. Rapp DE, Orvieto MA, Lucioni A, et al. Intra-operative prostate examination: predictive value and effect on margin status. BJU Int 2005;96:1005-8.
11. Salomon L, Anastasiadis AG, Johnson CW, et al. Seminal vesicle involvement after radical prostatec-tomy: predicting risk factors for progression. Urology 2003;62:304-9.
12. Guillonneau B, Cathelineau X, Doublet JD, et al. Laparoscopic radical prostatectomy: assessment after 550 procedures. Crit Rev Oncol Hematol 2002;43:123-33.
13. Guillonneau B, el-Fettouh H, Baumert H, et al. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. J Urol 2003;169:1261-6.
14. Rabbani F, Bastar A, Fair WR. Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of technique.[see comment]. J Urol 1998;160:1727-33
15. Swindle P, Eastham JA, Ohori M, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 2005;174:903-7.
16. Alsikafi NF, Brendler CB. Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J Urol 1998;159:1281-5.
17. Eastham JA, Kattan MW, Riedel E, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003;170(6:Pt 1):2292-5
18. Khan MA, Partin AW, Mangold LA, et al. Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer. Urology 2003;62:866-71
19. Richman M, McLaughlin S, Maygarden S, et al. Initial incision of lateral pelvic fascia and early ligation of vascular pedicles during radical prostatectomy: potential to reduce positive margin rates. BJU Int 2005;95:40-5.
20. Sofer M, Hamilton-Nelson KL, et al. Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression. J Urol 2002;167:2453-6.
21. Vis AN, Schroder FH, van der Kwast TH. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 2006;50:258-65.
22. Cohn JH, El-Galley R. Radical prostatectomy in a community practice. J Urol 2002;167:224-8
23. Graefen M, Hammerer P, Michl U, et al. Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology 1998;51:437-42.
24. Martinez-Pineiro L, Caceres F, Sanchez C, et al. Learning curve of laparoscopic radical prostatectomy in a university teaching hospital: experience after the first 600 cases. Eur Urol Suppl 2006;5:914-24
25. Orvieto MA, Alsikafi NF, Shalhav AL, et al. Impact of surgical margin status on long-term cancer control after radical prostatectomy. BJU Int 2006;98:1199-203.
26. Palisaar RJ, Noldus J, Graefen M, et al. Influence of nerve-sparing (NS) procedure during radical prosta-tectomy (RP) on margin status and biochemical failure. Eur Urol 2005;47:176-84
27. Salomon L, Anastasiadis AG, Antiphon P, et al. Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancer. Urol Int 2003;70:291-6.
28. Marcovich R, Wojno KJ, Wei JT, et al. Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. Urology 2000;55:904-8
29. Blute ML, Bostwick DG, Bergstralh EJ, et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 1997;50:733-9
30. Deliveliotis C, Protogerou V, Alargof E, et al. Radical prostatectomy: bladder neck preservation and pub-oprostatic ligament sparing-effects on continence and positive margins. Urology 2002;60:855-8
31. Kausik SJ, Blute ML, Sebo TJ, et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer 2002;95:1215-9.
32. Sofer M, Hamilton-Nelson KL, et al. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol 2002;20:1853-8.
33. Ward JF, Zincke H, Bergstralh EJ, et al. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol 2004;172(4 Pt 1):1328-32.
34. Aydin H, Tsuzuki T, Hernandez D, et al. Positive proximal (bladder neck) margin at radical prostatec-tomy confers greater risk of biochemical progression. Urology 2004;64:551-5
35. Pettus JA, Weight CJ, Thompson CJ, et al. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J Urol 2004;172:129-32
36. Guazzoni G, Cestari A, Naspro R, et al. Intra and peri-operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: results from a prospective, randomised, single-surgeon study. Eur Urol 2006;50:98-104.
37. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346:1138-44.
38. Kundu SD, Roehl KA, Eggener SE, et al. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004;172(6 pt 1):2227-31.
39. Bianco FJ, Jr., Riedel ER, Begg CB, et al. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.[see comment]. J Urol 2005;173:2099-103.
40. Ponholzer A, Brossner C, Struhal G, et al. Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria. World J Urol 2006;24:325-30.
41. Catalona WJ, Carvalhal GF, Mager DE, et al. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999;162:433-8.
42. Burkhard FC, Kessler TM, Fleischmann A, et al. Nerve sparing open radical retropubic prostatectomy-does it have an impact on urinary continence? J Urol 2006;176:189-95.
43. Lowe BA. Comparison of bladder neck preservation to bladder neck resection in maintaining postrostatectomy urinary continence. Urology 1996;48:889-93.
44. Anastasiadis AG, Benson MC, Rosenwasser MP, et al. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible. Prostate Cancer Prostatic Dis 2003;6:56-60.
45. Heidenreich A, Varga Z, Von KR. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.[see comment]. J Urol 2002;167:1681-6.
46. Lance RS, Freidrichs PA, Kane C, et al. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int 2001;87:61-5
47. Maffezzini M, Seveso M, Taverna G, et al. Evaluation of complications and results in a contemporary series of 300 consecutive radical retropubic prostatectomies with the anatomic approach at a single institution. Urology 2003;61:982-6.
48. Tewari A, Peabody JO, Fischer M, et al. An operative and anatomic study to help in nerve sparing during laparoscopic and robotic radical prostatectomy. Eur Urol 2003;43:444-54
49. Lee DK, Allareddy V, O'Donnell MA, et al. Does the interval between prostate biopsy and radical prosta-tectomy affect the immediate postoperative outcome? BJU Int 2006;97:48-50
50. Nuttall GA, Cragun MD, Hill DL, et al. Radical retropubic prostatectomy and blood transfusion. Mayo Clin Proc 2002;77:1301-5.
51. Cannon GM Jr, Pound CR, Landsittel DP, et al. Perineural invasion in prostate cancer biopsies is not associated with higher rates of positive surgical margins. Prostate 2005;63:336-40
52. Lilleby W, Fossa SD, Waehre HR, et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999;43:735-43.
53. Bianco FJ, Jr., Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology 2005;66(5 Suppl):83-94
54. Clark T, Parekh DJ, Cookson MS, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003;169:145-7
55. Briganti A, Chun FKH, Salonia A, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006;50:1006-13
56. Berglund RK, Sadetsky N, Duchane J, et al. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect the 5-year failure rates for low, intermediate and high risk prostate can-cer: results from CaPSURE. J Urol 2007;177:526-30.
57. Joslyn SA, Konety BR. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 2006;68:121-5.
58. Masterson TA, Bianco FJ Jr, Vickers AJ, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006;175:1320-4
59. Allaf ME, Palapattu GS, Trock BJ, et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004;172(5 Pt 1):1840-4.
60. Bhatta-Dhar N, Reuther AM, Zippe C, et al. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology 2004;63:528-31.
61. Fergany A, Kupelian PA, Levin HS, et al. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. Urology 2000;56:92-5
62. DiMarco DS, Zincke H, Sebo TJ, et al. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 2005;173:1121-5
63. Bader P, Burkhard FC, Markwalder R, et al. Is a limited lymph node dissection an adequate staging pro-cedure for prostate cancer? J Urol 2002;168:514-8.
64. Bader P, Burkhard FC, Markwalder R, et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?[see comment]. J Urol. 2003 Mar;169(3):849-54.
65. Parra RO, Isorna S, Perez MG, et al. Radical perineal prostatectomy without pelvic lymphadenectomy: selection criteria and early results. J Urol 1996;155:612-5.
66. Burkhard FC, Bader P, Schneider E, et al. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 2002;42:84-92.
67. Pagliarulo V, Hawes D, Brands FH, et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 2006;24:2735-42.
68. Rogers E, Gurpinar T, Dillioglugil O, et al. The role of digital rectal examination, biopsy Gleanson sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer. Br J Urol 1996;78:419-25.
69. Alagiri M, Colton MD, Seidmon EJ, et al. The staging pelvic lymphadenectomy: implications as an adjunc-tive procedure for clinically localized prostate cancer. Br J Urol 1997;80:243-6.
70. Miyake H, Sakai I, Harada K, et al. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy? Int J Urol 2005;12:739-44
71. Wawroschek F, Wagner T, Hamm M, et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 2003;43:132-6.
72. Weckermann D, Wawroschek F, Harzmann R. Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy? Eur Urol 2005;47:45-51
73. Weckermann D, Goppelt M, Dorn R, et al. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of <10 ng/mL and biopsy Gleason score of <6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 2006;97:1173-8.